High throughput artificial membrane permeability assay for blood-brain barrier

European Journal of Medicinal Chemistry

Volumn 38, Issue 3, 2003, Pages 223-232

  Di, Li ^a   Kerns, Edward H ^a   Fan, Kristi ^a   McConnell, Oliver J ^a   Carter, Guy T ^b  

^a PFIZER INC   (United States)

^b WYETH RESEARCH   (United States)

Author keywords

Artificial membrane; Blood brain barrier; Brain penetration; CNS; PAMPA; Permeability

Indexed keywords

ALDOSTERONE; ALPRAZOLAM; ASTEMIZOLE; ATENOLOL; CAFFEINE; CHLORPROMAZINE; CIMETIDINE; CLOBAZAM; CLONIDINE; CORTICOSTERONE; DESIPRAMINE; DIAZEPAM; DOPAMINE; ENOXACIN; ESTRADIOL; HYDROCORTISONE; IMIPRAMINE; ISOXICAM; LOMEFLOXACIN; LOPERAMIDE; NORFLOXACIN; OFLOXACIN; OXAZEPAM; PIROXICAM; PROGESTERONE; PROMAZINE; TENOXICAM; TERFENADINE; TESTOSTERONE; THIOPENTAL;

ARTICLE; ARTIFICIAL MEMBRANE; ASSAY; BLOOD BRAIN BARRIER; MEMBRANE PERMEABILITY; PREDICTION; REPRODUCIBILITY; SCREENING; VALIDATION PROCESS;

EID: 84962359573     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00012-6     Document Type: Article

References (47)

1. Clark D.E., Pickett S. Drug Discov. Today. 5:2000;49-58.
2. George A. Current Opin. Drug Discov. Dev. 2:1999;286-292.
3. Kerns E. J. Pharm. Sci. 90:2001;1838-1858.
4. Kerns E., Di L. Current Opin. Med. Chem. 2:2002;87-98.
5. Van Asperen J., Mayer U., Van Tellingen O., Beijnen J.H. J. Pharm. Sci. 86:1997;881-884.
6. Audus K., Borchardt R. Handbook Exp. Pharmacol. 100:1991;43-70.
7. Pardridge W.M. J. Neurochemistry. 7:1998;1781-1792.
8. Tamai I., Tsuji A. J. Pharm. Sci. 89:2000;1371-1388.
9. Levin V.A. J. Med. Chem. 23:1980;682-684.
10. Young R.C., Mitchell R.C., Brown T.H., Ganellin C.R., Griffiths R., Jones M., Rana K.K., Saunders D., Smith I.R., Sore N.E., Wilks T.J. J. Med. Chem. 31:1988;656-671.
11. Reichel A., Begley D.J. Pharm. Res. 15:1998;1270-1274.
12. Clark D.E. J. Pharm. Sci. 88:1999;815-821.
13. Platts J.A., Abraham M.H., Zhao Y.H., Hersey A., Ijaz L., Butina D. Eur. J. Med. Chem. 36:2001;719-730.
14. Gratton J.A., Abraham M.H., Bradbury M.W., Chadha H.S. J. Pharm. Pharmacol. 49:1997;1211-1216.
15. Fischer H., Gottschlich R., Seelig A. J. Membr. Biol. 165:1998;201-211.
16. Seelig A., Gottschlich R., Devant R.M. Proc. Natl. Acad. Sci. USA. 91:1994;68-72.
17. Audus K., Ng L., Wang W., Borchardt R.T. Pharm. Biotechnol. 8:1996;239-258.
18. Abraham M.H., Chadha H.S., Mitchell R.C. J. Pharm. Sci. 83:1994;1257-1268.
19. Lombardo F., Blake J.F., Curatolo W.J. J. Med. Chem. 39:1996;4750-4755.
20. Norinder U., Sjöberg P., Österberg T. J. Pharm. Sci. 87:1998;952-959.
21. Kansy M., Senner F., Gubernator K. J. Med. Chem. 41:1998;1007-1010.
22. Wohnsland F., Faller B. J. Med. Chem. 44:2001;923-930.
23. Zhu C., Jiang L., Chen T., Hwang K. Eur. J. Med. Chem. 37:2002;399-407.
24. Crivori P., Cruciani G., Carrupt P., Testa B. J. Med. Chem. 43:2000;2204-2216.
25. Gratton J.A., Lightman S.L., Bradbury M.W. J. Physiol. 470:1993;651-663.
26. Jones D.R., Hall S.D., Jackson E.K., Branch R.A., Wilkinson G.R. J. Pharmacol. Exp. Ther. 245:1988;816-822.
27. McCall A.L., Millington W.R., Wurtman R.J. Life Sci. 31:1982;2709-2715.
28. Martindale N.O. Reynolds J.E.F. The Extra Pharmacopoeia. 1989;Pharmaceutical Press, London.
29. Kulkarni S.K., Mehta A.K., Kunchandy J. Drugs Today. 20:1984;497-507.
30. Pardrigde W.M. Endocr. Rev. 2:1981;103-123.
31. Awouters F.H.L., Niemegeers C.J.E., Janssen P.A.J. Arzneim. Forsch. 33:1983;381-388.
32. Bayliss P.F.C., Duncan A.S.M. Br. J. Clin. Pharmacol. 2:1975;527-531.
33. B.B. Hofman, R.J. Lefkowitz, in: J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.), Goodman and Gillmans. The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1996, pp. 199-248.
34. Scheld W.M. Rev. Infect. Dis. 11:(Suppl. 5):1989;S1194-S1202.
35. Jolliet P., Simon N., BrJe F., Urien S., Pagliara A., Carrupt P.A., Testa B., Tillement J.P. Pharm. Res. 14:1997;650-656.
36. Heykants J., Michiels M., Knaeps A., Brugmans J. Arzneim. Forsch. 24:1974;1649-1653.
37. Weiner M. Arzneim. Forsch. 32:1982;1193-1195.
38. Young C., Mitchell R.C., Brown T.H., Ganellin C.R., Griffiths R., Jones M., Rana K.K., Saunders D., Smith I.R., Sore N.E., Wilks T.J. J. Med. Chem. 31:1998;656-671.
39. Selivonchick D.P., Roots B.I. Lipids. 12:1976;165-169.
40. Bénistant C., Dehouck M., Fruchart J., Cecchelli R., Lagarde M. J. Lipid Res. 36:1995;2311-2319.
41. Van Kalken C.K., Broxterman H.J., Pinedo H.M., Feller N., Dekker H., Lankelma J., Giaccone G. Br. J. Cancer. 67:1993;284-289.
42. Schinkel A.H., Wagenaar E., Carla A.A.M., van Deemter L. J. Clin. Invest. 97:1996;2517-2524.
43. Brown A., Griffiths R., Harvey C.A., Owen D.A.A. J. Pharmacol. 87:1986;569-578.
44. Davies A.J., Harinda V., McEwan A., Ghose R.R. Br. Med. J. 298:1989;325.
45. Raeissi S.D., Hidalgo I.J., Segura-Aguilar J., Artursson P. Pharma. Res. 16:1999;625-632.
46. Miertus S., Scrocco E., Tomasi J. Chem. Phys. 55:1981;117-129.
47. Barone V., Cossi M. J. Phys. Chem. A. 102:1998;1995-2001.